We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Reference sheet · Immune · CPC catalog code MIFI-001
Full physicochemical data (sequence, molecular formula, molecular weight, CAS) is documented on the upstream certificate of analysis. Request the current lot COA from the supplier before use — values may vary between manufacturing runs.
Reference standards in the Immune class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.
Melanocyte-Stimulating Hormone-Release Inhibiting Factor sits within the Immune research class (CPC reference MIFI-001). Immune peptides can serve as MHC-I / MHC-II epitopes, cytokine mimetics, TLR modulators, or antigenic tags. Function is measured by receptor engagement, cytokine release, or downstream T-cell / macrophage activation. Investigators typically incorporate Melanocyte-Stimulating Hormone-Release Inhibiting Factor as a reference standard, tool ligand, or substrate in the assay contexts listed above. ELISA, ELISpot, tetramer staining, and flow cytometry are the standard readouts.
Melanocyte-Stimulating Hormone-Release Inhibiting Factor (CPC catalog code MIFI-001) is a synthetic immunology research peptide in the immune category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
Published and internal research programs use Melanocyte-Stimulating Hormone-Release Inhibiting Factor as a reference standard in immune workflows — for example, mhc / tcr binding and t-cell activation assays and cytokine release and inflammation modeling. Human clinical evidence is not established.
No. Melanocyte-Stimulating Hormone-Release Inhibiting Factor is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
In a immune workflow, Melanocyte-Stimulating Hormone-Release Inhibiting Factor is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. ELISA, ELISpot, tetramer staining, and flow cytometry are the standard readouts.
Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.